<DOC>
	<DOCNO>NCT02057419</DOCNO>
	<brief_summary>The purpose study answer follow question : ( ) sexual reproductive health ( SRH ) delivery method characteristic play role user preference specific SRH method ; ( b ) understand interplay salient SRH product characteristic effective use ; ( c ) effective use differ indication ( e.g. , whether product contraception lubrication ) ; ( ) knowledge help product developer well understand design new SRH product develop behavioral ( point-of-care ) intervention optimize use ?</brief_summary>
	<brief_title>Women 's Input Sexual Health</brief_title>
	<detailed_description>Background : Sexual reproductive health ( SRH ) global public health priority . Providing efficacious SRH technology great likelihood use great impact woman 's health . Critical use `` acceptability . '' However , current conceptualization adherence acceptability fail fully articulate account pattern use non-use . This research hypothesize new model use , Effective Use , require . If correct , developer utilize Effective Use model , shift current `` acceptability = adherence '' paradigm would offer new insight development SRH technology result increase use improve SRH outcomes . If model fully realize , woman best reproductive health technology science provide . The impact global public health would far-reaching , affect reproductive health woman men : decreasing STI incidence , minimize unplanned pregnancy , decrease morbidity mortality due range reproductive health condition . Conditions : There 2 experimental condition : sexual lubricant use contraceptive use . [ NOTE : The protocol revise . Protocol 1 longer recruit - Protocol 1 : Each participant use 3 different SRH product 3 month . Recruitment Protocol 2 ongoing contraceptive use condition . - Protocol 2 : Each participant use 1 product 6 month , 2 product , 3 month . This dependent user 's choice . ] The sexual lubricant use condition include gel , film , capsule . The contraceptive use condition include gel , intravaginal ring , oral contraceptive pill . The order participant experience delivery method randomize . Methodology Data Collection : Volunteers ( N~20-30 ) first screen study use brief questionnaire . Those interested contraception eligible base response prescreen complete clinical screening visit ( contraceptive arm ) pregnancy test . Those interested lubricant eligible base response prescreen , eligible clinical screening ( contraception arm ) , complete survey ask question demographic sexual reproductive history . During course study , participant evaluate three study product ( contraceptive OR sexual lubricant ) . Each product use three consecutive month . Participants randomly assign order try three product . They give ( lubricant ) , prescribe ( contraceptive ) three month supply product begin use period . Participants require complete brief phone survey ( &lt; 5 minute ) every day , begin day start first product evaluation period continue complete final study visit ( approximately 9 month ) . The phone survey include short set question sexual behavior product use time since last phone survey ( 24 hour ) . About month , participant require complete web survey experience study product . Every three month , participant meet research staff , necessary , study clinician . All participant test pregnancy , give , prescribe , next study product . Participants also complete individual in-depth interview study staff experience study . Participants repeat step final ( third ) study product . After participant try three product , meet clinician ( contraceptive arm ) follow clinically contraception option post-study participation . All participant complete final survey ask experience three study product , kind product , , might interested use future . Participants also complete final in-depth interview .</detailed_description>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>age 18 45 prescreening , report vaginal sex man past month prescreening , pregnant ( selfreport , confirm V1 , V2 , V3 urine HcG test ) report intention become pregnant course study , report negative unknown HIV status , report need contraceptive product and/or sexual lubricant ( primary present need determines study condition ) , willing able provide inform consent . selfreport pregnancy , positive urine pregnancy test Visits 1 , 2 , 3 , intend become pregnant course study , selfreport breast feeding , selfreport vaginal delivery reproductive surgical procedure past 30 day , selfreport HIVpositive , selfreport diagnose active sexually transmit infection ( STI ) past 12 month , selfreport allergy sensitivity study product , cell phone internet access , unable unwilling give inform consent , condition , opinion study clinician ( ) principle investigator , would compromise participant 's ability participate study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>contraception</keyword>
	<keyword>contraceptive method</keyword>
	<keyword>sexual lubricant</keyword>
	<keyword>user experience</keyword>
	<keyword>adherence</keyword>
	<keyword>User experience : impact use contraceptive method</keyword>
	<keyword>User experience : impact use sexual lubricant</keyword>
</DOC>